Rosenblatt J E, Sloan L M, Bestrom J E
Mayo Clinic, Rochester, Minnesota 55905, USA.
Diagn Microbiol Infect Dis. 1995 Jul;22(3):275-8. doi: 10.1016/0732-8893(95)00045-c.
A commercially available enzyme-linked immunoassay (ELISA) was compared to an indirect hemagglutination test (IHA) for the detection of antibodies to Entamoeba histolytica on 225 patients' serums. All of the 107 serums that had IHA titers of < 32 (interpreted as excluding the presence of invasive amebiasis) were ELISA negative. Sixty-three of 68 (93%) serums that had IHA titers of > or = 128 (interpreted as indicative of the presence of active or recent infection) were ELISA positive. Fifty serums had IHA titers of 32 or 64 that were considered "equivocal," and the ELISA results for these were: six positive, 35 negative, and nine "intermediate" (optical density values between the arbitrary positive cutoff and the low positive control). It was concluded that "intermediate" (and negative) ELISA results should be interpreted as excluding the presence of invasive amebiasis. Using these criteria, the results obtained with this ELISA appear to compare favorably with those of the "gold standard" IHA. Therefore, this ELISA provides a reliable alternative to the IHA for the serologic diagnosis of amebiasis, which may be advantageous for some laboratories in terms of lower cost, shorter test time, and improved efficiency.
将一种市售的酶联免疫吸附测定(ELISA)与间接血凝试验(IHA)进行比较,以检测225例患者血清中抗溶组织内阿米巴的抗体。107份IHA滴度<32(解释为排除侵袭性阿米巴病的存在)的血清,ELISA检测均为阴性。68份IHA滴度≥128(解释为表明存在活动性或近期感染)的血清中,63份(93%)ELISA检测为阳性。50份IHA滴度为32或64的血清被认为“结果可疑”,其ELISA检测结果为:6份阳性,35份阴性,9份“中间值”(光密度值介于任意阳性临界值和低阳性对照之间)。得出的结论是,ELISA“中间值”(和阴性)结果应解释为排除侵袭性阿米巴病的存在。按照这些标准,该ELISA获得的结果似乎与“金标准”IHA的结果相当。因此,对于阿米巴病的血清学诊断,该ELISA为IHA提供了一种可靠的替代方法,在成本更低、检测时间更短和效率更高方面,对一些实验室可能具有优势。